{
    "clinical_study": {
        "@rank": "73841", 
        "arm_group": {
            "arm_group_label": "Pre- and perinterventional hypothermia", 
            "arm_group_type": "Experimental", 
            "description": "Cooling will be initiated by the application of cooling pads in the out-of-hospital setting followed by an infusion of 1000-2000ml of cold saline. In the cath lab a endovascular cooling catheter will be placed into the inferior vena cava via a femoral vein to achieve a core temperature of <35\u00b0C prior to revascularization."
        }, 
        "brief_summary": {
            "textblock": "The primary goal in the treatment of acute myocardial infarction is to reperfuse the\n      ischemic myocardium to reduce infarct size. Animal data and human data suggest that\n      whole-body cooling to temperatures below 35\u00b0C before revascularisation can additionally\n      reduce infarct size and therefore improves outcome in these patients.\n\n      The purpose of the study is to determine the feasibility and safety of a combined cooling\n      strategy started in the out-of-hospital arena for achieving pre-reperfusion hypothermia in\n      patients with acute st-elevation myocardial infarction."
        }, 
        "brief_title": "Target Temperature Management In Myocardial Infarction - A Pilot Study", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "ST-elevation Myocardial Infarction", 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Myocardial Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age between 18 and 75 years\n\n          -  Immediately transfer to cath-lab is possible\n\n          -  Anterior or inferior ST-Elevation myocardial infarction\n\n          -  ST-Segment elevation of >0.2mV in 2 or more anatomically contiguous leads\n\n          -  Duration of symptoms <6 hours\n\n        Exclusion Criteria:\n\n          -  Participation in another study\n\n          -  Patients presenting with cardiac arrest\n\n          -  Tympanic temperature of <35.0\u00b0C prior enrolment\n\n          -  Thrombolysis therapy\n\n          -  Previous myocardial infarction in medical history\n\n          -  Previous percutaneous coronary intervention or coronary artery bypass graft\n\n          -  Severe heart failure (defined as a New York Heart Association (NYHA) score of III or\n             IV), Killip class II through IV at presentation\n\n          -  Clinical signs of infection\n\n          -  End-stage kidney disease or hepatic failure\n\n          -  Recent stroke (within the last six month)\n\n          -  Conditions that may be exacerbated by hypothermia, such as haematological dyscrasias,\n             oral anticoagulant treatment with international normalized radio >1.5, severe\n             pulmonary disease\n\n          -  Pregnancy. Women of childbearing potential are excluded\n\n          -  Allergy to meperidine, buspirone, magnesium, or polyvinyl chloride\n\n          -  Use of a monoamine oxidase inhibitor such as selegiline in the previous 14 days"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "19", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01864343", 
            "org_study_id": "STATIM-Pilot", 
            "secondary_id": "MUW_492/2011"
        }, 
        "intervention": {
            "arm_group_label": "Pre- and perinterventional hypothermia", 
            "description": "Surface cooling with EMCOOLS flex pads (out-of-hospital); Infusion of 1000ml to 2000ml of cold saline (out-of-hospital); central-venous cooling (Philips Innercool RTx)", 
            "intervention_name": "EMCOOLS flex pad; Philips Innercool RTx", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Myocardial Infarction", 
            "Myocardial Reperfusion Injury", 
            "Reperfusion Injury", 
            "Anterior Wall Myocardial Infarction", 
            "Inferior Wall Myocardial Infarction", 
            "Myocardial Ischemia"
        ], 
        "lastchanged_date": "May 24, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Vienna", 
                    "country": "Austria", 
                    "zip": "1090"
                }, 
                "name": "Medical University of Vienna"
            }
        }, 
        "location_countries": {
            "country": "Austria"
        }, 
        "number_of_arms": "1", 
        "official_title": "Target Temperature Management In Myocardial Infarction - A Pilot Study", 
        "overall_official": {
            "affiliation": "Medical University of Vienna, Dept. of Emergency Medicine", 
            "last_name": "Christoph Testori, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Austria: Agency for Health and Food Safety", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Blood temperature will be recorded at the time of first wire-crossed lesion of the infarct related coronary stenosis", 
            "measure": "Feasibility of a combined cooling strategy for achieving a core temperature of <35.0\u00b0C at the time of reperfusion of the infarct related artery", 
            "safety_issue": "No", 
            "time_frame": "Time of reperfusion of the culprit lesion in st-elevation myocardial infarction (expected average 120 minutes)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01864343"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical University of Vienna", 
            "investigator_full_name": "Dr. Christoph Testori", 
            "investigator_title": "Department of Emergency Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Incidence of major adverse cardiac events as defined as: death, heart failure, pulmonary edema, recurrent MI, malignant arrhythmias (i.e. ventricular fibrillation, sustained ventricular tachycardia) emergent stent revascularisation, any hospitalisation,  major/minor bleeding (according to TIMI-bleeding score), infection (clinical relevant infection with the need of systemic antimicrobiotic therapy) within a period of 45\u00b115 days", 
                "measure": "Safety of a combined cooling strategy as an adjunctive therapy on primary percutaneous coronary intervention in acute st-elevation myocardial infarction", 
                "safety_issue": "Yes", 
                "time_frame": "within 45 days (+/- 15 days)"
            }, 
            {
                "description": "Patients are monitored for incidence of shivering using a 4-point scale: 0, no shivering evident; 1, isolated facial or masticatory fasciculation; 2, peripheral shivering; 3, uncontrolled rigor during the cooling procedure (in average the first 4 hours)", 
                "measure": "Tolerability of a combined cooling strategy as an adjunctive therapy on primary percutaneous coronary intervention in acute st-elevation myocardial infarction", 
                "safety_issue": "No", 
                "time_frame": "during active cooling and rewarming (in average the first 4 hours)"
            }, 
            {
                "description": "The time to reperfusion of the infarct related artery is crucial in acute ST-elevation myocardial infarction. To evaluate if the cooling procedure has a substantial influence on this time frame we measure the time from first medical contact to reperfusion.", 
                "measure": "Time to revascularisation (first medical contact to balloon time)", 
                "safety_issue": "No", 
                "time_frame": "Time of reperfusion (in average 120 minutes)"
            }
        ], 
        "source": "Medical University of Vienna", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medical University of Vienna", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}